Comorbidity and prognostic factors on admission in a COVID-19 cohort of a general hospital.

Autor:	Martos Pérez F; Servicio de Medicina Interna, Hospital Costa del Sol, Marbella, Málaga, España. Electronic address: pacomartos1@gmail.com., Luque Del Pino J; Servicio de Medicina Interna, Hospital Costa del Sol, Marbella, Málaga, España., Jiménez García N; Servicio de Medicina Interna, Hospital Costa del Sol, Marbella, Málaga, España., Mora Ruiz E; Servicio de Neumología, Hospital Costa del Sol, Marbella, Málaga, España., Asencio Méndez C; Servicio de Medicina Interna, Hospital Costa del Sol, Marbella, Málaga, España., García Jiménez JM; Servicio de Neumología, Hospital Costa del Sol, Marbella, Málaga, España., Navarro Romero F; Servicio de Medicina Interna, Hospital Costa del Sol, Marbella, Málaga, España., Núñez Rodríguez MV; Servicio de Medicina Interna, Hospital Costa del Sol, Marbella, Málaga, España.
Jazyk:	English; Spanish; Castilian
Zdroj:	Revista clinica espanola [Rev Clin Esp] 2020 Jun 26. Date of Electronic Publication: 2020 Jun 26.
DOI:	10.1016/j.rce.2020.05.017
Abstrakt:	Antecedents and Objective: To describe clinical features, comorbidity, and prognostic factors associated with in-hospital mortality in a cohort of COVID-19 admitted to a general hospital. Material and Methods: Retrospective cohort study of patients with COVID-19 admitted from 26th February, who had been discharged or died, up to 29th April, 2020. A descriptive study and an analysis of factors associated with intrahospital mortality were performed. Results: Out of the 101 patients, 96 were analysed. Of these, 79 (82%) recovered and were discharged, and 17 (18%) died in the hospital. Diagnosis of COVID-19 was confirmed by polymerase chain reaction to SARS-CoV-2 in 92 (92.5%). The mean age was 63 years, and 66% were male. The most frequent comorbidities were hypertension (40%), diabetes mellitus (16%) and cardiopathy (14%). Patients who died were older (mean 77 vs 60 years), had higher prevalence of hypertension (71% vs 33%), and cardiopathy (47% vs 6%), and higher levels of lactate dehydrogenase (LDH) and reactive C protein (mean 662 vs 335UI/L, and 193 vs 121mg/L respectively) on admission. In a multivariant analysis the variables significantly associated to mortality were the presence of cardiopathy (CI 95% OR 2,58-67,07), levels of LDH≥345IU/L (CI 95% OR 1,52-46,00), and age≥65 years (CI 95% OR 1,23-44,62). Conclusions: The presence of cardiopathy, levels of LDH≥345IU/L and age ≥65 years are associated with a higher risk of death during hospital stay for COVID-19. This model should be validated in prospective cohorts. (Copyright © 2020 Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI). All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu